The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil

Japanese Journal of Cancer Research

Volumn 93, Issue 3, 2002, Pages 329-339

  Masuda, Muneyuki ^a,b   Toh, Satoshi ^a   Koike, Koji ^a   Kuratomi, Yuichiro ^a   Suzui, Masumi ^b   Deguchi, Atsuko ^b   Komiyama, Sohtaro ^a   Weinstein, I Bernard ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b Columbia University ^*  (United States)

Author keywords

Apoptosis; Concomitant chemoradiotherapy; Cyclin D1; Retinoid

Indexed keywords

CHOCORA A; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P27; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOL PALMITATE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; ENZYME ACTIVATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOLECULAR MECHANICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CYCLIN D1; DNA-BINDING PROTEINS; DRUG SYNERGISM; FLOW CYTOMETRY; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOBLOTTING; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0036235654     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb02176.x     Document Type: Article

References (59)

1. Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells
2. Enhancement of radiation effect on transformed fibroblastic cells by a synergistic combination of 5-fluorouracil and polyenes in vitro
3. Synergistic combination therapy of 5-fluorouracil, vitamin A and cobalt-60 radiation upon head and neck tumors
4. Synergistic combination therapy of 5-fluorouracil, vitamin A, and cobalt-60 radiation for head and neck tumors-antitumor combination therapy with vitamin A
5. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A
6. Potentiation of cytostatic effect of sulfur- or chlorine-containing purines and related ribonucleosides by amphotericin-B on cultured mouse leukemia cells
7. Inhibition of stomal recurrence in laryngectomy with preoperative FAR therapy. A statistical evaluation
8. Clinical evaluation of hypopharyngeal cancer
9. FAR therapy for improving laryngeal preservation in T2N0 glottic carcinoma
10. Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic
11. Molecular epidemiology and retinoid chemoprevention of head and neck cancer
12. Induction of apoptosis in maxillary sinus cancer cells by 5-fluorouracil, vitamin A and radiation (FAR) therapy
13. Serine/threonine protein kinases and apoptosis
14. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation
15. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage
16. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein
17. Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid
18. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide
19. Epidermal growth factor receptor family and chemosensitization
20. STAT signaling in head and neck cancer
21. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells
22. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
23. Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element
24. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells
25. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
26. Epidermal growth factor receptor-mediated Stat3 signaling blocks apoptosis in head and neck cancer
27. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
28. Cyclin D1 overexpression in primary hypopharyngeal carcinomas
29. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells
30. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation
31. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
32. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event
33. p27Kip1: A key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line
34. Posttranslational mechanisms contribute to the suppression of specific cyclin: CDK complexes by all-trans retinoic acid in human bronchial epithelial cells
35. Cyclin D1 proteolysis: A retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells
36. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
37. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide
38. Multiple functions of p27(Kip1) and its alterations in tumor cells: A review
39. Abnormalities in cell cycle control in cancer and their clinical implications
40. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer
41. Potential molecular prognostic markers in head and neck squamous cell carcinomas
42. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
43. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: Implications for lung cancer development
44. Overexpression of retinoic acid receptor β induces growth arrest and apoptosis in oral cancer cell lines
45. Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells
46. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids
47. Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines
48. All-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells
49. Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: A rationale for combination therapy with chemotherapeutic agents
50. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death
51. All-trans-retinoic acid modulates the radiosensitivity of proliferating cells
52. Cisplatin induces a persistent activation of JNK that is related to cell death
53. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M
54. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis
55. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
56. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines
57. Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells
58. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines
59. Enhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck cancers